Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Journal of Molecular Biology|March 28, 2022
Intrinsically Disordered N-terminal Domain (NTD) of p53 Interacts with Mitochondrial PTP Regulator Cyclophilin DJing Zhao, Xinyue Liu, Alan Blayney, et al.The Journal of Physical Chemistry. B|October 17, 2017
Quantification of Membrane Protein-Detergent Complex InteractionsAaron J Wolfe, Wei Si, Zhengqi Zhang, et al.Journal of Medicinal Chemistry|February 4, 2021
Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53John A Gilleran, Xin Yu, Alan J Blayney, et al.Physical Review Letters|October 27, 2011
Spatial fluctuations of loose spin coupling in CuMn/Co multilayersT Saerbeck, N Loh, D Lott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2018
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer TherapeuticsXin Yu, Samuel Kogan, Ying Chen, et al.Molecular Cancer Therapeutics|June 15, 2019
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper BindingSaif Zaman, Xin Yu, Anthony F Bencivenga, et al.Molecular Pharmacology|February 25, 2015
Synthetic metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an ionophoreAdam R Blanden, Xin Yu, Aaron J Wolfe, et al.The EMBO Journal|November 12, 2017
Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clientsMark R Woodford, Rebecca A Sager, Elijah Marris, et al.Nature Communications|June 30, 2016
The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug bindingMark R Woodford, Diana M Dunn, Adam R Blanden, et al.Nature Communications|February 13, 2021
EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interactionJing Zhao, Alan Blayney, Xiaorong Liu, et al.Pageof 11